Cell Source, Inc. Deferred Foreign Income Tax Expense (Benefit)
Cell Source, Inc. (CLCS) reported Deferred Foreign Income Tax Expense (Benefit) of $11.66 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-04-07
- Cell Source, Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was $11.66K.
- Cell Source, Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was -$70.91K, a 123.32% decline from fiscal 2022.
- Cell Source, Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was $304.00K.
- Cell Source, Inc. deferred foreign income tax expense (benefit) for fiscal 2021 was -$118.44K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2024-12-31 | $11.66K 10-K · filed 2026-04-07 | |
| 2023-12-31 | -$70.91K 10-K · filed 2026-04-07 | |
| 2022-12-31 | $304.00K 10-K · filed 2024-06-24 | |
| 2021-12-31 | -$118.44K 10-K · filed 2023-08-08 | |
| 2020-12-31 | -$111.73K 10-K · filed 2022-04-15 | -$883.03K 10-K · filed 2021-04-15 |
| 2019-12-31 | -$836.32K 10-K · filed 2021-04-15 | -$971.77K 10-K · filed 2020-03-30 |
| 2018-12-31 | -$403.59K 10-K · filed 2020-03-30 | -$226.00K 10-K · filed 2019-04-01 |
| 2017-12-31 | -$357.00K 10-K · filed 2019-04-01 | |
| 2016-12-31 | -$390.00K 10-K · filed 2018-07-25 | |
| 2015-12-31 | -$358.00K 10-K · filed 2018-07-25 | |
| 2014-12-31 | -$1.04M 10-K · filed 2016-04-14 | |
| 2013-12-31 | -$446.00K 10-K · filed 2015-03-13 |